Convergent evolution dynamics of SARS-CoV-2 and HIV surface envelope glycoproteins driven by host cell surface receptors and lipid rafts: lessons for the future

J Fantini, H Chahinian, N Yahi - International journal of molecular …, 2023 - mdpi.com
Although very different, in terms of their genomic organization, their enzymatic proteins, and
their structural proteins, HIV and SARS-CoV-2 have an extraordinary evolutionary potential …

SARS-CoV-2: an update on the biological interplay with the human host

G Lippi, F Sanchis-Gomar, C Mattiuzzi, BM Henry - COVID, 2023 - mdpi.com
Coronavirus Disease 2019 (COVID-19) is an infectious respiratory illness caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease, first identified in the …

COV2Var, a function annotation database of SARS-CoV-2 genetic variation

Y Feng, J Yi, L Yang, Y Wang, J Wen… - Nucleic Acids …, 2024 - academic.oup.com
The COVID-19 pandemic, caused by the coronavirus SARS-CoV-2, has resulted in the loss
of millions of lives and severe global economic consequences. Every time SARS-CoV-2 …

Impact of vaccination on SARS-CoV-2 evolution and immune escape variants

D Jena, A Ghosh, A Jha, P Prasad, SK Raghav - Vaccine, 2024 - Elsevier
Vaccines and host genetic factors can influence the SARS-CoV-2 evolution and emergence
of new variants. Even vaccinated cases get affected as virus continues to evolve, raising …

Molecular characterization of SARS-CoV-2 Omicron clade and clinical presentation in children

R Scutari, V Fox, V Fini, A Granaglia, AC Vittucci… - Scientific Reports, 2024 - nature.com
Since its emergence, SARS-CoV-2 Omicron clade has shown a marked degree of variability
and different clinical presentation compared with previous clades. Here we demonstrate that …

Mapping the Evolutionary Space of SARS-CoV-2 Variants to Anticipate Emergence of Subvariants Resistant to COVID-19 Therapeutics

RA Rojas Chávez, M Fili, C Han… - PLOS Computational …, 2024 - journals.plos.org
New sublineages of SARS-CoV-2 variants-of-concern (VOCs) continuously emerge with
mutations in the spike glycoprotein. In most cases, the sublineage-defining mutations vary …

[HTML][HTML] Characterization of SARS-CoV-2 genetic evolution in vaccinated and non-vaccinated patients from the Kenyan population

S Oyola - Research Square, 2023 - ncbi.nlm.nih.gov
Vaccination is a key control measure of COVID-19 by preventing severe effects of disease
outcomes, reducing hospitalization rates and death, and increasing herd immunity …

[PDF][PDF] Comment on: Antiviral effect of Evusheld in COVID-19 hospitalized patients infected with pre-Omicron or Omicron variants: a modelling analysis of the …

A Lacout, X Azalbert, C Reverbel… - The Journal of …, 2024 - pdfs.semanticscholar.org
We read with great interest the Beaulieu et al. article 1. The article shows that the drug
Evusheld exhibits antiviral activity, with differences between variants. We have several …

Características de la proteína S del virus SARS-CoV-2 y las implicaciones clínicas en pacientes del Hospital Regional de Alta Especialidad “Dr. Juan Graham …

GC Baeza Flores - 2023 - ri.ujat.mx
Introducción: El SARS-CoV-2 representa la causa de morbimortalidad más importante a
nivel mundial durante los últimos años. Está formado por 4 proteínas. De importancia para …